The CD43 antibody (Clone MT1) is a high-quality mouse monoclonal antibody developed by GeneBioSolution for immunohistochemistry (IHC) applications on formalin-fixed, paraffin-embedded (FFPE) tissues. CD43, also known as leukosialin or sialophorin, is a surface glycoprotein widely expressed on T lymphocytes, monocytes, granulocytes, and some B-cell subsets, making it a valuable marker for both research and diagnostic pathology. This antibody delivers sensitive and specific detection of CD43 antigen, producing distinct membrane staining patterns with minimal background. The MT1 clone is widely recognized for its robust performance in differentiating T-cell lymphomas, certain B-cell lymphomas, and other hematologic malignancies, aiding in the accurate classification of lymphoproliferative disorders. In addition to its clinical utility, CD43 is also important in studying immune regulation, leukocyte adhesion, and signaling pathways. The CD43 MT1 clone supports applications in both routine pathology labs and advanced research environments, providing consistent, reproducible, and high-quality staining results. Each GeneBioSolution antibody undergoes rigorous quality control, ensuring batch-to-batch consistency, optimal performance on automated stainers, and compatibility with standard IHC protocols.
Humans; others not tested
Immunohistochemistry (formalin-fixed, paraffin-embedded tissues)
Buffer with protein carrier and preservative
Store at 2ºC to 8ºC
Tonsil, CLL/SLL, or lymph node
Cell membrane
IgG
Recombinant full-length human SPN protein